Department of Biochemistry & Pharmacology,
School of Biomedical Sciences,
Faculty of Medicine,
Dentistry and Health Sciences,
Department of Biochemistry & Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences
Maytham Hussein has not added Biography.
If you are Maytham Hussein and would like to personalize this page please email our Author Liaison for assistance.
Lipidomic Analysis of the Outer Membrane Vesicles from Paired Polymyxin-Susceptible and -Resistant Clinical Isolates.
International journal of molecular sciences Aug, 2018 | Pubmed ID: 30103446
A Comparative Study of Outer Membrane Proteome between Paired Colistin-Susceptible and Extremely Colistin-Resistant Klebsiella pneumoniae Strains.
ACS infectious diseases 12, 2018 | Pubmed ID: 30232886
Mechanistic Insights From Global Metabolomics Studies into Synergistic Bactericidal Effect of a Polymyxin B Combination With Tamoxifen Against Cystic Fibrosis MDR .
Computational and structural biotechnology journal , 2018 | Pubmed ID: 30546859
The impact of backbone N-methylation on the structure-activity relationship of Leu -teixobactin.
Journal of peptide science : an official publication of the European Peptide Society Sep, 2019 | Pubmed ID: 31389086
Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 12, 2019 | Pubmed ID: 31611351
Synthesis and structure-activity relationships of teixobactin.
Annals of the New York Academy of Sciences 01, 2020 | Pubmed ID: 31792983
Effective Strategy Targeting Polymyxin-Resistant Gram-Negative Pathogens: Polymyxin B in Combination with the Selective Serotonin Reuptake Inhibitor Sertraline.
ACS infectious diseases 06, 2020 | Pubmed ID: 32427476
The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study.
mSystems May, 2020 | Pubmed ID: 32457238
The Antimicrobial Activity of Cannabinoids.
Antibiotics (Basel, Switzerland) Jul, 2020 | Pubmed ID: 32668669
Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination.
JCI insight 09, 2020 | Pubmed ID: 32853178
Polymyxin B combinations with FDA-approved non-antibiotic phenothiazine drugs targeting multi-drug resistance of Gram-negative pathogens.
Computational and structural biotechnology journal , 2020 | Pubmed ID: 32952938
Unique mechanistic insights into pathways associated with the synergistic activity of polymyxin B and caspofungin against multidrug-resistant .
Computational and structural biotechnology journal , 2022 | Pubmed ID: 35284046
Mechanisms Underlying Synergistic Killing of Polymyxin B in Combination with Cannabidiol against : A Metabolomic Study.
Pharmaceutics Apr, 2022 | Pubmed ID: 35456620
Rajnikant Sharma1,
Shekhar Yeshwante1,
Quentin Vallé1,
Maytham Hussein2,
Varsha Thombare2,
Sean Michael McCann1,
Robert Maile3,4,5,
Jian Li6,
Tony Velkov2,
Gauri Rao1
1UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill,
2Department of Biochemistry & Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne,
3Department of Microbiology & Immunology, University of North Carolina School of Medicine,
4Department of Surgery, University of North Carolina at Chapel Hill,
5Curriculum in Toxicology and Environmental Medicine, University of North Carolina at Chapel Hill,
6Department of Microbiology, Monash Biomedicine Discovery Institute, Monash University
Sara Oberrauch1,
Jing Lu1,
Linda Cornthwaite-Duncan1,
Maytham Hussein1,
Jian Li2,
Gauri Rao3,
Tony Velkov1
1Department of Biochemistry & Pharmacology, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne,
2Department of Microbiology, Biomedicine Discovery Institute, Monash University,
3UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。